AIAI Group Corporation (6557.T)
Tokyo, JP
AIAI Group Corporation, headquartered in Tokyo, Japan, provides a diverse range of services in the childcare and elder care sectors. In Japan, its operations encompass managing nursery schools, offering child development support offices, and delivering after-school day services. For the elderly, the company operates various facilities including housing, residential fee-based nursing homes, and home-visit nursing care services. Furthermore, AIAI Group is engaged in the planning, development, sales, and operation of information and communication technology (ICT) solutions tailored specifically for the childcare and nursing care fields. Founded in 2007, the company was formerly known as global bridge HOLDINGS Co., Ltd. before officially changing its name to AIAI Group Corporation in January 2022.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +0.40% | -35.83% | -37.97% | -43.98% | -47.90% | -47.97% | -43.35% | +103.27% | +53.61% | +187.64% | +187.64% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
| Rating | 2024-11 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 0 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Medical - Care Facilities: +10.2%+12.0% ★ Q1'26: +7.1% (vs Q1'25)
-
EPS growth Medical - Care Facilities: +19.2%+47.1% ★ Q1'26: +43.2% (vs Q1'25)
-
FCF margin FCF growth · Medical - Care Facilities: +32.0%+3.6% Q1'26: +0.0% (vs Q1'25)
-
EBIT margin Medical - Care Facilities: +11.3%+7.6% Q1'26: +10.2% (vs Q1'25)
-
ROIC Medical - Care Facilities: +6.8%+4.2% Q1'26: +7.0% (vs Q1'25)
-
Share dilution Medical - Care Facilities: +0.0%+0.1% Q1'26: -2.1% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Medical - Care Facilities: 0.99×10.95× Q1'26: 8.20× (vs Q1'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Mar 2020 actual |
Mar 2021 actual |
Mar 2022 actual |
Mar 2023 actual |
Mar 2024 actual |
Mar 2025 actual |
|---|---|---|---|---|---|---|
| Revenue |
8.32B
est: 5.96B (+39.6%)
|
9.58B
est: 8.37B (+14.5%)
|
9.73B
est.
|
10.82B
est: 10.63B (+1.8%)
|
11.82B
est: 11.83B (-0.1%)
|
13.07B
est: 13.12B (-0.4%)
|
| EBITDA |
-848.27M
est: 539.19M (-257.3%)
|
328.91M
est: 757.29M (-56.6%)
|
880.55M
est.
|
879.51M
est: 961.99M (-8.6%)
|
1.26B
est: 3.66B (-65.5%)
|
1.44B
est: 2.81B (-48.7%)
|
| EBIT |
-1.38B
est: 153.57M (-999.1%)
|
-352.01M
est: 215.69M (-263.2%)
|
250.79M
est.
|
80.71M
est: 273.99M (-70.5%)
|
532.31M
est: 3.15B (-83.1%)
|
733.47M
est: 2.57B (-71.5%)
|
| Net Income |
150.73M
est: 254.30M (-40.7%)
|
93.29M
est: 1.29B (-92.8%)
|
120.92M
est.
|
-506.11M
est: -374.56M (-35.1%)
|
353.26M
est: 345.73M (+2.2%)
|
421.88M
est: 460.73M (-8.4%)
|
| SGA |
1.35B
est: 658.36M (+104.8%)
|
1.17B
est: 924.66M (+26.9%)
|
1.08B
est.
|
931.41M
est: 1.17B (-20.7%)
|
849.65M
est: 1.23B (-31.2%)
|
1.04B
est: 1.25B (-16.7%)
|
| EPS |
28.75
est: 38.80 (-25.9%)
|
17.19
est: 196.85 (-91.3%)
|
18.45
est.
|
-90.17
est: -57.15 (-57.8%)
|
57.36
est: 52.75 (+8.7%)
|
65.31
est: 70.20 (-7.0%)
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-08 | B | 3/5 | 1/5 | 5/5 | 4/5 | 1/5 | 3/5 | 2/5 |
| 2026-05-07 | B | 3/5 | 1/5 | 5/5 | 4/5 | 1/5 | 3/5 | 2/5 |
| 2026-05-01 | B | 3/5 | 1/5 | 5/5 | 4/5 | 1/5 | 3/5 | 2/5 |
| 2026-04-30 | B | 3/5 | 1/5 | 5/5 | 4/5 | 1/5 | 3/5 | 2/5 |
| 2026-04-28 | B | 3/5 | 1/5 | 5/5 | 5/5 | 1/5 | 3/5 | 2/5 |
| 2026-04-27 | B | 3/5 | 1/5 | 5/5 | 5/5 | 1/5 | 3/5 | 2/5 |
| 2026-04-24 | B | 3/5 | 1/5 | 5/5 | 5/5 | 1/5 | 3/5 | 2/5 |
| 2026-04-23 | B | 3/5 | 1/5 | 5/5 | 5/5 | 1/5 | 3/5 | 2/5 |
| 2026-04-22 | B | 3/5 | 1/5 | 5/5 | 5/5 | 1/5 | 3/5 | 2/5 |
| 2026-04-21 | B | 3/5 | 1/5 | 5/5 | 5/5 | 1/5 | 3/5 | 2/5 |
| 2026-04-20 | B | 3/5 | 1/5 | 5/5 | 5/5 | 1/5 | 3/5 | 2/5 |
| 2026-04-17 | B | 3/5 | 1/5 | 5/5 | 5/5 | 1/5 | 3/5 | 2/5 |
| 2026-04-16 | B | 3/5 | 1/5 | 5/5 | 5/5 | 1/5 | 3/5 | 2/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
This company is not held by any ETF in our universe.
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Akira Kimoto | Chief Operating Officer & Director | — | male |
| Jo Sadamatsu | Chairman, Chief Executive Officer & President | — | male |
| Takao Toda | Chief Financial Officer & Director | — | male |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for 6557.T
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.

MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
